Brief: Scandinavian Chemotech Gets New Approval In Japan For Its TSE For Deep Seated Tumours
March 24 (Reuters) - Scandinavian ChemoTech AB
CMOTECb.ST :
* SCANDINAVIAN CHEMOTECH RECEIVES NEW APPROVAL IN JAPAN FOR
ITS
TSE FOR DEEP SEATED TUMOURS
* PATENT PROTECTS INNOVATION USED FOR TSE THERAPY IN DEEP
SEATED
TUMOURS AND SECONDARY BONE CANCER
Source text for Eikon: ID:nWkr5cvlrD
Further company coverage: CMOTECb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Scandinavian ChemoTech AB
See all newsBrief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue
Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Brief: ChemoTech Q1 Sales SEK 2.798 Million